3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
543
Triple Negative Breast Neoplasms
97
Ovarian Neoplasms
58
Colorectal Neoplasms
50
Prostatic Neoplasms
46
Carcinoma, Non-Small-Cell Lung
44
Neoplasms
38
Lung Neoplasms
33
Melanoma
29
Endometrial Neoplasms
29
Neoplasm Metastasis
28
Stomach Neoplasms
26
Pancreatic Neoplasms
26
Uterine Cervical Neoplasms
25
Squamous Cell Carcinoma of Head and Neck
22
Colonic Neoplasms
20
Head and Neck Neoplasms
18
Carcinoma, Renal Cell
18
Esophageal Neoplasms
16
Sarcoma
14
Advanced Breast Cancer
14
Small Cell Lung Carcinoma
13
Urinary Bladder Neoplasms
12
Liver Neoplasms
11
Carcinoma, Transitional Cell
11
Kidney Neoplasms
10
Carcinoma, Intraductal, Noninfiltrating
10
Brain Neoplasms
10
Lymphedema
9
Anatomic Stage I Breast Cancer AJCC v8
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Intraductal Neoplasms
×
Breast
×
30 days
×
Clear all
NCT07213791
2026-06-04
FiREBOLT
Eli Lilly and Company
Phase 1
Recruiting
241 enrolled